Status:
RECRUITING
SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly
Lead Sponsor:
University Hospital, Caen
Conditions:
Sarcopenia
Bladder Cancer
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Sarcopenia is associated with lower prognosis in solid tumors, but this has not been studied in bladder carcinoma requiring cystectomy. According to EWGSOP recommendations, the diagnosis of sarcopeni...
Eligibility Criteria
Inclusion
- confirmed urothelial bladder carcinoma ( RTUV)
- indication of radical cystectomy
- Able, informed and with informed consent for the study
- affiliated to the social security system
- talking French
Exclusion
- Life expectancy \<6 months
- other active malignant tumors or other severe concomitant chronic pathologies affecting the general condition of the patient and / or likely to limit compliance with the requirements of the study.
- treatments incompatible with the study: previous corticosteroid treatment prolonged for more than one month (induces iatrogenic sarcopenia).
Key Trial Info
Start Date :
October 30 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT03362801
Start Date
October 30 2017
End Date
February 1 2026
Last Update
July 19 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Caen University Hospital
Caen, France
2
APHM
Marseille, France
3
Rouen UH
Rouen, France